Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline

Annals of the Rheumatic Diseases

Volumn 62, Issue 3, 2003, Pages 267-269

  Robertson, L P ^a   Marshall, R W ^b   Hickling, P ^a  

^a ROYAL CORNWALL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; COLCHICINE; CORTICOSTEROID; DILTIAZEM; DOXYCYCLINE; MATRIX METALLOPROTEINASE; MINOCYCLINE; OXYTETRACYCLINE; PROBENECID; TETRACYCLINE DERIVATIVE; WARFARIN;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIBODY TITER; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLEEDING; CALCIUM BINDING; CARBON DIOXIDE LASER; CLINICAL ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE DURATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; ENZYME INHIBITION; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INJECTION PAIN; LOW DRUG DOSE; NAUSEA; OPEN STUDY; OUTCOMES RESEARCH; PAIN; PRESCRIPTION; PRIORITY JOURNAL; SKIN CALCIFICATION; SKIN DISCOLORATION; SKIN ULCER; SYSTEMIC SCLEROSIS; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBODIES, ANTINUCLEAR; CALCINOSIS; FEMALE; HAND; HUMANS; MIDDLE AGED; MINOCYCLINE; SCLERODERMA, SYSTEMIC; SKIN DISEASES, METABOLIC;

EID: 0037370821     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.3.267     Document Type: Article

References (15)

1. Cohen H, Solomon V, Alferiev IS, Breuer E, Ornoy A, Patlas N, et al. Bisphosphonates and tetracycline: experimental models for their evaluation in calcium related disorders. Pharm Res 1998;15:606-13.
2. Donahue H J, Iijima K, Goligorsky MS, Rubin CT, Rifkin BR. Regulation of cytoplasmic calcium concentration in tetracycline treated osteoclasts. J Bone Min Res 1992;7:1313-18.
3. Gabler WL, Creamer HR. Suppression of human neutrophil functions by tetracyclines. J Peridontal Res 1991;26:52-8.
4. Yoshida S, Torikai K. The effects of warfarin on calcinosis in a patient with systemic sclerosis. J Rheumatol 1993;20:1233-5.
5. Skuterud E, Sydnes OA, Haavik TK. Calcinosis in dermatomyositis treated with probenecid. Scand J Rheumatol 1981;10:92-4.
6. Fuchs D, Fruchter L, Fishel, Holtzman M, Yaron M. Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis. Clin Rheumatol 1986;5:527-30.
7. Dolan AL, Kassimos D, Gibson T, Kingsley GH. Diltiazem induces remission of calcinosis in scleroderma. Br J Rheumatol 1995;34:576-8.
8. Lee SS, Feisenstein J, Tanzer FR. Calcinosis cutis circumscripta: treatment with intralesional corticosteroid. Arch Dermatol 1978;114:1080-1.
9. Bottomley WW, Goodfield MJ, Sheehan-Dare RA. Digital calcification in systemic sclerosis: effective treatment with good tissue preservation using the carbon dioxide laser. Br J Dermatol 1996;135:302-4.
10. Cheek CC, Heymann HO. Dental and oral discolourations associated with minocycline and other tetracycline analogues. J Esther Dent 1999;11:43-8.
11. Perry HD, Golub LM. Systemic tetracycline in the treatment of non-infected corneal ulcers. Ann Opthalmol 1985;17:742-4.
12. Berk MA, Lorincz AL. The treatment of bullous phemphigoid with tetracycline and niacinamide. Arch Dermatol 1986;122:670-4.
13. O'Dell JR, Blakely KW, Mallek JA, Eckhoff PJ, Leff RD, Wees SJ, et al. Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocydine and hydroxychloroquine. Arthritis Rheum 2001;44:2235-41.
14. Le CH, Morales A, Trentham D. Minocydine in early diffuse scleroderma. Lancet 1998;352:1755-6.
15. Hallet MB, Campbell AK. Is intracellular calcium the trigger for oxygen radical production by polymorphonuclear leucocytes? Cell Calcium 1984;5:1-19.